Hemophilia A (Factor VIII Deficiency) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
A total of 721 Hemophilia A (Factor VIII Deficiency) clinical trials were conducted as of February 2024. The Hemophilia A clinical trial report provides a comprehensive understanding of the Hemophilia A (Factor VIII Deficiency) clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor type and the prominent sponsors associated with the trials.
Key Regions | · Asia-Pacific
· Europe · North America · Middle East and Africa · South and Central America |
Key Countries | · United States
· United Kingdom · Italy · Germany · Spain · France · Japan |
Key Sponsor Types | · Company
· Institution · Government |
Leading Sponsors | · Novo Holdings AS
· Bayer AG · Takeda Pharmaceutical Co Ltd · F. Hoffmann-La Roche Ltd · Pfizer Inc · Sanofi · CSL Ltd |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Hemophilia A Clinical Trials Segmentation by Regions and Countries
Europe led the Hemophilia A clinical trials landscape with more than 30% of the clinical trials conducted as of February 2024.
The key regions considered for Hemophilia A clinical trials analysis are Asia-Pacific, Europe, North America, Middle East and Africa, and South and Central America.
In the country-wise analysis, the US had the highest number of Hemophilia A clinical trials, as of February2024. Germany had the highest average patient enrollment of Hemophilia A clinical trials, during the same time.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, Italy had the highest proportion of Hemophilia A (Factor VIII Deficiency) to Hematological Disorders clinical trials as of February 2024.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Turkey had the highest proportion of Hemophilia A (Factor VIII Deficiency) to Hematological Disorders clinical trials as of February 2024.
Hemophilia A Clinical Trials Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional Insights into the Hemophilia A (Factor VIII Deficiency) Clinical Trials
Hemophilia A Clinical Trials Segmentation by Sponsor Types
The key sponsor types for Hemophilia A clinical trials are company, institution, and the government. As of February 2024, more than 70% of Hemophilia A clinical trials conducted were sponsored by company sponsor type, followed by the institution type.
Hemophilia A Clinical Trials Analysis by Sponsor Type, 2023 (%)
Buy the Full Report for More Insights into the Hemophilia A (Factor VIII Deficiency) Clinical Trials Sponsor Types
Hemophilia A Clinical Trials - Competitive Landscape
In 2023, Novo Holdings AS conducted the highest number of Hemophilia A clinical trials.
A few of the leading sponsors for Hemophilia A clinical trials are:
- Novo Holdings AS
- Bayer AG
- Takeda Pharmaceutical Co Ltd
- Hoffmann-La Roche Ltd
- Pfizer Inc
- Sanofi
- CSL Ltd
Hemophilia A Clinical Trials Analysis by Leading Companies, 2023 (%)
Buy Full Report to Know More About the Leading Players of Hemophilia A (Factor VIII Deficiency) Clinical Trials
Segments Covered in the Report
Hemophilia A (Factor VIII Deficiency) Clinical Trials Regional Outlook (2023)
- Asia-Pacific
- Europe
- North America
- Middle East and Africa
- South and Central America
Hemophilia A (Factor VIII Deficiency) Clinical Trials Country Outlook (2023)
- United States
- United Kingdom
- Italy
- Germany
- Spain
- France
- Japan
Hemophilia A (Factor VIII Deficiency) Clinical Trials Sponsor Type Outlook (2023)
- Company
- Institution
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape.
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and endpoint status.
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) of the company.
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with a reason for accomplishment.
- The report provides enrollment trends for the past five years.
- The report provides the latest news for the past three months.
Reasons to Buy
- Assists in formulating key investment strategies.
- Helps in identifying time-saving and cost-efficient locations to conduct clinical trials.
- Provides top-level analysis of the global clinical trials market to help in identifying key business opportunities.
- Helps in understanding trial count and enrollment trends by country in the global therapeutics market.
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials.
- Facilitates clinical trial assessment of the indication on a global, regional, and country level.
Bayer AG
Takeda Pharmaceutical Co Ltd
F. Hoffmann-La Roche Ltd
Pfizer Inc
Sanofi
CSL Ltd
Octapharma AG
Swedish Orphan Biovitrum AB
Baxter International Inc
Table of Contents
Table
Figures
Frequently asked questions
-
Which region accounted for the highest number of Hemophilia A clinical trials in February 2024?
Europe accounted for the highest number of Hemophilia A clinical trials as of February 2024.
-
Which country conducted the highest number of Hemophilia A clinical trials in February 2024?
The US conducted the highest number of Hemophilia A clinical trials as of February 2024.
-
Which sponsor type was the most prominent in the Hemophilia A clinical trials in February 2024?
As of February 2024, most of the Hemophilia A clinical trials conducted were sponsored by company sponsor type.
-
Which are the leading sponsors of Hemophilia A clinical trials?
A few of the leading sponsors of Hemophilia A clinical trials are Novo Holdings AS, Bayer AG, Takeda Pharmaceutical Co Ltd, F. Hoffmann-La Roche Ltd, Pfizer Inc, Sanofi, and CSL Ltd, among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.